Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics Revenue

Agile Therapeutics had revenue of $5.58M in the quarter ending June 30, 2024, with 1.33% growth. This brings the company's revenue in the last twelve months to $21.57M, up 32.22% year-over-year. In the year 2023, Agile Therapeutics had annual revenue of $19.59M with 80.02% growth.

• Revenue (ttm): $21.57M
• Revenue Growth: +32.22%
• P/S Ratio: 0.31
• Revenue / Employee: $1,135,211
• Employees: 19
• Market Cap: 10.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	19.59M	8.71M	80.02%
Dec 31, 2022	10.88M	6.78M	165.40%
Dec 31, 2021	4.10M	3.35M	447.53%
Dec 31, 2020	749.00K	-	-
Dec 31, 2019	-	-	-